National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)
WHEREAS it is provided by
sub-section 101 (4) of the
AND WHEREAS the Pharmaceutical
Benefits Advisory Committee has recommended to the Minister that the following
drugs and medicinal preparations be prescribed as pharmaceutical benefits under
section 85 of the
AND WHEREAS it is desirable, amongst
other things, to prescribe, for the purposes of section 85 of the
NOW THEREFORE I, the
Governor-General of the Commonwealth of Australia, acting with the advice of
the Federal Executive Council, hereby make the following Regulations under the
Dated 27 November 1980.
ZELMAN COWEN
Governor-General
By His Excellency’s Command,
MICHAEL MACKELLAR
Minister of State for Health
_______________
Commencement
1. These Regulations shall come into operation on 1 December 1980.
Prescribed pharmaceutical benefits, &c., for purposes of section 88A of the Act
2. Regulation 14 of the National Health (Pharmaceutical Benefits) Regulations is amended—
(a) by omitting sub-regulations (1) and (2) and substituting the following sub‑regulations:
“(1) Each pharmaceutical benefit the name of which is specified in column 2 of an item in Schedule 5 is prescribed for the purposes of section 88A of the Act.
“(2) The following circumstances are prescribed in relation to each pharmaceutical benefit the name of which is specified in column 2 of an item in Schedule 5:
(a) where a class of persons is specified in column 3 of that item—that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;
(b) where a disease or condition is specified in column 3 of that item—
(i) if sub-paragraph (ii) does not apply—that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or
(ii) if the disease or condition is specified in relation to a specified class of persons—that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;
(c) where a purpose is specified in column 3 of that item—that the pharmaceutical benefit is to be supplied for that purpose;
(d) where it is specified in column 3 of that item that the written authority of the Permanent Head is required-that an application for the written authority of the Permanent Head in relation to the writing of a prescription for the supply of the pharmaceutical benefit has been made by the medical practitioner intending to write the prescription and the Permanent Head has, in accordance with sub-regulation (3), approved the application.”;
(b) by omitting from sub-regulation (3) “under sub-regulation (2)” and substituting “referred to in paragraph (2) (d)”;
(c) by omitting from sub-regulation (3) “or participating dental practitioner”; and
(d) by omitting sub-regulation (4).
Schedules 1, 2, 3, 4 and 5
3. Schedules 1, 2, 3, 4 and 5 of the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:
DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS OR, EXCEPT AS SPECIALLY PROVIDED, USED IN PHARMACEUTICAL BENEFITS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
___________
Sub-regulations 10 (3) and (4)
ALLOWABLE COMPOUNDS (IF ANY) OF CERTAIN DRUGS OR MEDICINAL PREPARATIONS
1 | Acepifylline | ‑ |
2 | Acetylcysteine | ‑ |
3 | Acetylsulphafurazole | ‑ |
4 | Acrylic Resin | ‑ |
5 | Adrenaline Acid Tartrate, B.P. |
|
6 | Adrenaline Hydrocholride | ‑ |
7 | “ALBUMAID XP” | ‑ |
8 | Aluminium Sodium Silicate | ‑ |
9 | Amiloride Hydrochloride |
|
10 | Aminocaproic Acid | ‑ |
11 | “AMINOGRAN FOOD SUPPLEMENT” | ‑ |
12 | “AMINOGRAN MINERAL MIXTURE” | ‑ |
13 | Aminophylline | ‑ |
14 | Amoxycillin Trihydrate | Purified Water, B.P., with Amoxycillin Trihydrate |
15 | Amphotericin | ‑ |
16 | Ampicillin Trihydrate | Purified Water, B.P., with Ampicillin Trihydrate |
17 | Antazoline Sulphate | Naphazoline Nitrate with Antazoline Sulphate |
18 | Ascorbic Acid | Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary Ferrous Sulphate mixture Prescribers’ List
|
19 | Atropine Sulphate B.P. |
|
20 | Bacitracin |
|
21 | Bacitracin Zinc |
|
22 | “BANISH” | ‑ |
23 | Beclomethasone Dipropionate | ‑ |
24 | Benzathine Penicillin |
|
25 | Benzyl Benzoate, B.P. | ‑ |
26 | Benzyl Benzoate Application, B.P. | ‑ |
27 | Benzylpenicillin Potassium |
|
28 | Benzylpenicillin Sodium | Procaine Penicillin with Benzylpenicillin Sodium |
29 | Betamathasone | Betamethasone Acetate with Betamethasone |
30 | Betamethasone Acetate | Betamethasone with Betamethasone Acetate |
31 | Betamethasone Dipropionate | ‑ |
32 | Betamethasone Phosphate | ‑ |
33 | Betamethasone Valerate | ‑ |
34 | Bisacodyl |
|
35 | Brompheniramine Maleate | ‑ |
36 | Bufexamac | ‑ |
37 | Butyl Monoester Polymer | Butyl Monoester Polymer with Isopropyl Alcohol |
38 | Calciferol | ‑ |
39 | Calcium Chloride |
|
40 | Calcium Lactate-Gluconate |
|
41 | Carbidopa | Levodopa, B.P., with Carbidopa |
42 | Cephalexin | Purified Water, B.P., with Cephalexin |
43 | Cephradine | Purified Water, B.P., with Cephradine |
44 | Ceratonia, B.P.C. 1949 | ‑ |
45 | Chloramine, B.P.C. | ‑ |
46 | Chloramphenicol, B.P | Polymyxin B Sulphate with Chloramphenicol, B.P. |
47 | Chloramphenicol Palmitate, B.P.C. | ‑ |
48 | Chlorhexidine Gluconate | ‑ |
49 | Chlorpheniramine Maleate | ‑ |
50 | Chlorpromazine Hydrochloride | ‑ |
51 | Chlortetracycline | ‑ |
52 | Chlortetracycline Hydrochloride | ‑ |
53 | Choline Theophyllinate | Guaiphenesin, B.P.C., with Choline Theophyllinate |
54 | Clemizole Tannate | ‑ |
55 | Clindamycin Palmitate Hydrochloride |
|
56 | Clotrimazole | ‑ |
57 | Cloxacillin Sodium | Purified Water, B.P., with Cloxacillin Sodium |
58 | Colistin Sulphate | Neomycin Sulphate with Colistin Sulphate |
59 | Cortisone Acetate | ‑ |
60 | Cyclizine Hydrochloride |
|
61 | Cyproheptadine Hydrochloride | ‑ |
62 | Danthron |
|
63 | Dapsone B.P. | Pyrimethamine with Dapsone |
64 | “DE-LACT INFANT” | ‑ |
65 | Desmopressin | ‑ |
66 | Dexamethasone |
|
67 | Dexamethasone Metasulphobenzoate |
|
68 | Dexchlorpheniramine Maleate | ‑ |
69 | Diazepam | ‑ |
70 | Dicyclomine Hydrochloride |
|
71 | Dienoestrol | ‑ |
72 | Difenoxin Hydrochloride |
|
73 | “DIGESTELACT” | ‑ |
74 | Digoxin | |
75 | Dihydrocodeine Tartrate | ‑ |
76 | Dimethicone, B.P.C. | ‑ |
77 | Dioctyl Sodium Sulphosuccinate, B.P.C. |
|
78 | Diphenhydramine Hydrochloride |
|
79 | Diphenoxylate Hydrochloride |
|
80 | Diphenylpyraline Hydrochloride | ‑ |
81 | Diphtheria Vaccine Adsorbed | Diphtheria and Tetanus Vaccine, Adsorbed |
82 | Doxylamine Succinate |
|
83 | Econazole Nitrate | ‑ |
84 | Ecothiopate Iodide | ‑ |
85 | Ergotamine Tartrate |
Caffeine with Ergotamine Tartrate |
86 | Erythromycin Estolate | ‑ |
87 | Erythromcyin Ethylsuccinate |
|
88 | Erythromycin Stearate | ‑ |
89 | Ethinyloestradiol | Ethynodiol Diacetate with Ethinyloestradiol Levonorgestrel with Ethinyloestradiol Norethisterone with Ethinyloestradiol Norethisterone Acetate with Ethinyloestradiol Norgestrel with Ethinyloestradiol |
90 | Ethosuximide | ‑ |
91 | Ethynodiol Diacetate | Ethinyloestradiol with Ethynodiol Diacetate Mestranol with Ethynodiol Diacetate |
92 | Fenoterol Hydrobromide | ‑ |
93 | Ferrous Aminoacetosulphate | ‑ |
94 | Fluclorolone Acetonide | ‑ |
95 | Flumethasone Pivalate | Clioquinol with Flumethasone Pivalate |
96 | Fluocortolone Hexanoate |
|
97 | Fluocortolone Pivalate |
|
98 | Fluphenazine Hydrochloride | ‑ |
99 | Folic Acid |
|
100 | Framycetin Sulphate |
|
101 | Frusemide | ‑ |
102 | Fusidic Acid | ‑ |
103 | “GALACTOMIN, FORMULA No. 17” | ‑ |
104 | ”GALACTOMIN, FORMULA No. 19” | ‑ |
105 | Gamma Benzene Hexachloride | ‑ |
106 | Gamma Benzene Hexachloride Cream, B.P. | ‑ |
107 | Glucose and Ketone Indicator-Urine | ‑ |
108 | Glucose Indicator-Blood | ‑ |
109 | Glucose Indicator-Urine | ‑ |
110 | “GLUCOSE NUTRAMIGEN” | ‑ |
111 | Gramicidin |
|
112 | Guaiphenesin, B.P.C. | Theophylline with Guaiphenesin, B.P.C. |
113 | Hydrochlorothiazide, B.P. |
|
114 | Hydrocortisone |
Neomycin Sulphate with Hydrocortisone
|
115 | Hydrocortisone Acetate | Neomycin Sulphate with Hydrocortisone Acetate |
116 | Hyoscine Hydrobromide, B.P. |
Papaveretum with Hyoscine Hydrobromide, B.P. |
117 | Hyoscyamine Hydrobromide |
|
118 | Hyoscyamine Sulphate |
|
119 | Idoxuridine | ‑ |
120 | Insulin Injection, Neutral Specially Purified |
|
121 | Insulin Isophane Injection, Specially Purified |
|
122 | “ISOMIL” | ‑ |
123 | Isoprenaline Hydrochloride | ‑ |
124 | Isopropyl Alcohol B.P |
|
125 | Isopropyl Monoester Polymer |
|
126 | “KETOVITE” Liquid | ‑ |
127 | Lauryldimethylbenzyl Ammonium Chloride |
|
128 | Levodopa, B.P. |
|
129 | Levonorgestrel | Levonorgestrel with Ethinyloestradiol |
130 | “LOCASOL” | ‑ |
131 | “LOFENALAC” | ‑ |
132 | Lypressin | ‑ |
133 | Magnesium Aluminium Hydroxide | ‑ |
134 | Magnesium Chloride |
|
135 | Magnesium Hydroxide, B.P.C. |
|
136 | Mebhydrolin Napadisylate, B.P.C. 1968 | ‑ |
137 | Medrysone | ‑ |
138 | Mestranol |
|
139 | Methylprednisolone | ‑ |
140 | Naphazoline Hydrochloride | ‑ |
141 | Naphazoline Nitrate | Antazoline Sulphate with Naphazoline Nitrate |
142 | Natamycin |
|
143 | Neomycin Sulphate |
Colistin Sulphate with Neomycin Sulphate Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate Hydrocortisone Acetate with Neomycin Sulphate Hydrocortisone with Neomycin Sulphate
Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate
|
144 | Neomycin Undecenoate | Bacitracin Zinc with Neomycin Undecenoate |
145 | Neostigmine Methylsulphate | ‑ |
146 | Nitrofurantoin | ‑ |
147 | Noradrenaline Acid Tartrate | ‑ |
148 | Norethisterone | Ethinyloestradiol with Norethisterone Mestranol with Norethisterone |
149 | Norethisterone Acetate | Ethinyloestradiol with Norethisterone Acetate |
150 | Norethynodrel | Mestranol with Norethynodrel |
151 | Norgestrel | Ethinyloestradiol with Norgestrel |
152 | Nortriptyline Hydrochloride | ‑ |
153 | Nystatin |
Tetracycline Hydrochloride with Nystatin |
154 | Orciprenaline Sulphate | ‑ |
155 | Oxytetracycline Hydrochloride, B.P. | ‑ |
156 | Oxethazaine |
|
157 | Pancreatin Enzyme, 4 times U.S.N.F.XIII strength | ‑ |
158 | Papaveretum, B.P.C. | Hyoscine Hydrobromide with Papaveretum, B.P.C. |
159 | Pectin |
|
160 | Pericyazine | ‑ |
161 | Phenethicillin Potassium |
|
162 | Pheniramine Maleate | ‑ |
163 | Phenoxymethylpenicillin (Benzathine or Hydrabamine salt) | ‑ |
164 | Phenytoin, B.P.C. | ‑ |
165 | Pholcodine | ‑ |
166 | Pituitary (Posterior Lobe), Powdered, B.P.C. | ‑ |
167 | “PK AID I” | ‑ |
168 | “PK AID II” | ‑ |
169 | Polyisobutylene | ‑ |
170 | Polymyxin B Sulphate |
Chloramphenicol with Polymyxin B Sulphate
|
171 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | ‑ |
172 | Prednisolone | ‑ |
173 | Prednisolone Acetate |
|
174 | Prednisolone Sodium Phosphate | ‑ |
175 | “PREGESTIMIL” | ‑ |
176 | Procaine Penicillin |
Benzylpenicillin Sodium with Procaine Penicillin |
177 | Promethazine Hydrochloride | ‑ |
178 | “PROSOBEE” | ‑ |
179 | Pyridoxine Hydrochloride |
|
180 | Pyrimethamine B.P. | Dapsone B.P., with Pyrimethamine B.P. Sulphadoxine with Pyrimethamine, B.P. |
181 | Salbutamol | ‑ |
182 | Salbutamol Sulphate | ‑ |
183 | Sodium Acetate |
|
184 | Sodium Acid Citrate | ‑ |
185 | Sodium Carboxymethylcellulose |
|
186 | Sodium Gluconate |
|
187 | Sodium Lactate |
|
188 | “SOYALAC” | ‑ |
189 | Sterculia | ‑ |
190 | Sulfadoxine | Pyrimethamine, B.P., with Sulfadoxine |
191 | Sulphafurazole | ‑ |
192 | Sulphamethizole | ‑ |
193 | Sulphamethoxazole | Trimethoprim with Sulphamethoxazole |
194 | Sulphaphenazole, B.P.C. | ‑ |
195 | Surgical Cement | ‑ |
196 | Surgical Cement Solvent | ‑ |
197 | Tacrine Hydrochloride | Morphine Sulphate with Tacrine Hydrochloride Morphine Hydrochloride with Tacrine Hydrochloride |
198 | Terbutaline Sulphate | ‑ |
199 | “TERIC N8” |
|
200 | Testosterone Decanoate |
|
201 | Testosterone Isocaproate | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
202 | Testosterone Phenylpropionate | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate |
203 | Testosterone Propionate | Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P.,Testosterone Isocaproate and Testosterone Decanoate |
204 | Tetanus Vaccine, Adsorbed | Diphtheria and Tetanus Vaccine, Adsorbed |
205 | Tetracycline, B.P.C. | Tetracycline, B.P.C., with a buffering agent Tetracycline, B.P.C., with a buffering agent and Nystatin |
206 | Tetracycline Hydrochloride | Tetracycline Hydrochloride with Nystatin |
207 | Thioridazine Hydrochloride | ‑ |
208 | Thiotepa | ‑ |
209 | Triamcinolone Acetonide | Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide |
210 | Triamterene B.P. | Hydrochlorothiazide, B.P. with Triamterene, B.P. |
211 | Triamterene B.P. | Trifluoperazine Hydrochloride |
212 | Triglycerides Oil, Medium Chain | ‑ |
213 | “TRIGLYDE” | ‑ |
214 | Trimethoprim | Sulphamethoxazole with Trimethoprim |
215 | Triprolidine Hydrochloride | ‑ |
216 | Urea | ‑ |
217 | Vidarabine | ‑ |
218 | Viprynium Embonate | ‑ |
219 | “ZERODOR” | ‑ |
220 | “ZOFF” | ‑ |
___________
and sub-regulation 35(1)
DRUGS AND MEDICINAL PREPARATIONS ADDITIONAL TO THE DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
___________
Regulation 12 and
sub-regulation 35 (1)
ADDITIVES
1 | Acetone, B.P.C. | 15 | Dextrose, B.P. |
2 | Alcohol (95%), B.P. | 16 | Dilute Alcohols, B.P. |
3 | Arachis Oil, B.P. | 17 | Ether, Solvent, B.P. |
4 | Boric Acid, B.P | 18 | Eucalyptus Oil, B.P. |
5 | Camphor, B.P. | 19 | Honey, Purified, B.P.C. |
6 | Castor Oil, B.P. | 20 | Industrial Methylated Spirit, B.P. |
7 | Chlorhexidine Acetate, B.P.C. | 21 | Linseed Oil, B.P. 1963 |
8 | Chlorhexidine Gluconate Solution, B.P | 22 | Maize Oil, B.P. |
9 | Chloroform, B.P. | 23 | Olive Oil, B.P. |
10 | Cineole, B.P.C. | 24 | Peppermint Oil, B.P. |
11 | Citronella Oil, B.P.C. | 25 | Sodium Thiosulphate, B.P. |
12 | Concentrated Anise Water, B.P.C | 26 | Syrup of Pholcodine Citrate, B.P.C. 1959 |
13 | Concentrated Cinnamon Water, B.P.C. | 27 | Turpentine Oil, B.P. |
14 | Concentrated Peppermint Water, B.P. |
___________
Sub-regulations 14 (1) and (2),
paragraphs 19 (1) (h) and 21 (1) (e)
and sub-regulation 22 (2)
PRESCRIBING OF PHARMACEUTICAL BENEFITS SUBJECT TO CONDITIONS AND RESTRICTIONS
1 | Acetylcysteine | Bronchiectasis Cystic fibrosis (mucoviscidosis) |
2 | Acrylic Resin | Ileostomy or colostomy conditions |
3 | Amantadine Hydrochloride | The treatment of Parkinson’s disease caused otherwise than by treatment with a drug |
4 |
| Treatment in hospital of patients suffering from severe haemorrhage associated with excessive fibrinolysis |
5 | “AMINOGRAN MINERAL MIXTURE” | Phenylketonuria |
6 | Ascorbic Acid Tablets, B.P. | Any disease or condition in a pensioner |
7 | Atenolol | Hypertension |
8 | Azathioprine Tablets, B.P. |
With the written authority of the Permanent Head—
|
9 | Baclofen |
|
10 | “BANISH” | Ileostomy or colostomy conditions |
11 | Beclomethasone Dipropionate Metered Aerosol Spray |
|
12 | Benzoin Compound Tincture, B.P.C., Aerosol Spray | Ileostomy or colostomy conditions |
13 | Betamethasone Acetate with Betamethasone Injection | Alopecia areata Granulomata, dermal Keloid Lichen planus hypertrophic Lichen simplex chronicus Local intra-articular or peri-articular infiltration Lupus erythematosus, chronic discoid Necrobiosis lipoidica Uveitis |
14 | Bisacodyl Suppositories, B.P |
Benefit is approved |
15 | Bleomycin Sulphate | Choriocarcinoma of the testis Embryonal cell carcinoma of the testis Lymphoma Squamous cell carcinoma |
16 | Butyl Monoester Polymer with Isopropyl Alcohol | Ileostomy or colostomy conditions |
17 |
| With the written authority of the Permanent Head—
|
18 | Calcium Carbonate, B.P., with Calcium Lactate-Gluconate | With the written authority of the Permanent Head—
|
19 | Calcium Carbonate, B.P., with Citric Acid Monohydrate, B.P., Compound Effervescent Tablets | With the written authority of the Permanent Head—
|
20 | Calcium Folinate | Antidote to folic acid antagonists |
21 | Carbenicillin Sodium |
Septicaemia, suspected or proven |
22 | Carbenoxolone Tablets, B.P. |
|
23 |
|
With the written authority of the Permanent Head—
|
24 | Cephaloridine | Endophthalmitis
|
25 | Cephalothin Sodium |
|
26 | Cephazolin Sodium |
|
27 |
| With the written authority of the Permanent Head—
|
28 | Cephradine for Injection |
|
29 | Charcoal Tablets | Ileostomy or colostomy conditions |
30 | Chlorambucil Tablets, B.P. |
With the written authority of the Permanent Head—
|
31 | Chloramine Deodorant Tablets and Powder | Ileostomy or colostomy conditions |
32 |
| Bacterial meningitis |
| Intraocular infections Rickettsioses | |
| Typhoid
| |
33 | Chlormethiazole | With the written authority of the Permanent Head—
Status epilepticus |
34 | Chlormethiazole Edisylate |
Status epilepticus |
35 | Chlorotrianisene Tablets | Carcinoma of the prostate |
36 |
| Chorea Hyperactive states of organic or toxic delirium |
| Major psychoses including— | |
|
| |
37 | Cholestyramine | With the written authority of the Permanent Head—
|
38 | Cimetidine | With the written authority of the Permanent Head—
|
39 |
|
|
39A | Clofibrate Capsules, B.P. | With the written authority of the Permanent Head—
|
40 | Clonazepam | Epilepsy |
41 |
|
|
| With the written authority of the Permanent Head—
| |
42 | Codeine Phosphate with Aspirin, Soluble Tablets | Any disease or condition in a pensioner |
43 |
| Malignant neoplasia |
44 |
| Pyocyaneus infection, other gram-negative infections where no other drug is effective |
45 | Cyanocobalamin Injection, B.P. |
Post-gastrectomy treatment Sub-acute combined degeneration of the cord |
46 |
|
|
| With the written authority of the Permanent Head—
| |
47 | Danazol | With the written authority of the Permanent Head—
|
48 | “DE-LACT INFANT” |
|
49 | Deodorant Detergent Solution
|
Ileostomy or colostomy conditions |
50 |
| For use in a hospital |
51 | Dexamphetamine Tablets, B.P. | With the written authority of the Permanent Head—
|
52 |
| Treatment in malignant neoplasia |
53 | Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride | Vomiting in pregnancy |
54 | “DIGESTELACT” | With the written authority of the Permanent Head—
|
55 | Dihydrotachysterol | With the written authority of the Permanent Head—
|
56 | Dimethicone Aerosol Spray | Ileostomy or colostomy conditions |
57 | Dimethicone Creams |
Use with surgical appliances |
58 |
|
|
|
| |
|
| |
59 | Diphemanil Methylsulphate | Amputees
|
60 | Dipyridamole | With the written authority of the Permanent Head-
|
61 |
|
|
62 | Ethacrynic Acid Tablets, B.P. | Patients who are hypersensitive to other oral diuretics |
63 | Ethyloestrenol Tablets, B.P. | With the written authority of the Permanent Head—
|
64 | Flucytosine | Invasive or systemic fungal infections such as candidiasis, cryptococcosis and chromoblastomycosis |
65 | Fluoxymesterone Tablets, B.P. | With the written authority of the Permanent Head—
|
66 |
| Chorea Hyperactive states of organic or toxic delirium Major psychoses including—
Malignant neoplasia (late stage) Radiation sickness |
67 | Fosfestrol Tetrasodium | Carcinoma of the prostate |
68 | Frusemide Tablets, B.P., 500 mg | Renal failure |
69 | Fusidic Acid |
With the written authority of the Permanent Head—
|
70 | “GALACTOMIN FORMULA No. 17” | With the written authority of the Permanent Head—
|
71 | “GALACTOMIN FORMULA No. 19” | With the written authority of the Permanent Head—
|
72 | Gentamicin Injection, B.P. |
With the written authority of the Permanent Head—
|
73 | “GLUCOSE NUTRAMIGEN” | With the written authority of the Permanent Head—
|
74 | Glycerol Suppositories, B.P. |
|
75 | Griseofulvin Tablets, B.P. | With the written authority of the Permanent Head—
|
76 |
| Chorea |
| Hyperactive states of organic or toxic delirium Malignant neoplasia (late stage) Radiation sickness Major psychoses including—
| |
77 | Hydrocortisone Acetate Injection, B.P. | Alopecia areata Granulomata, dermal Keloid Lichen planus hypertrophic Lichen simplex chronicus Local intra-articular or peri-articular infiltration Lupus erythematosus, chronic discoid |
78 | Hydrocortisone Sodiumnate Injection, 500 mg |
|
79 |
| Eye infections caused by Herpes Simplex Virus or by Vaccinia Virus |
80 | Influenza Vaccine |
|
81 |
|
Juvenile diabetes |
| Patients already stabilised on this type of insulin | |
82 | “ISOMIL” | With the written authority of the Permanent Head—
|
83 |
| Ileostomy or colostomy conditions |
84 | Kanamycin Injection, B.P. |
Septicaemia, including suspected septicaemia |
85 |
| With the written authority of the Permanent Head—
|
86 | Lactulose |
|
87 | Lincomycin Injection, B.P | Gram-negative anaerobic infections
|
88 | “LOCASOL” | With the written authority of the Permanent Head—
|
89 | Mafenide Acetate | With the written authority of the Permanent Head—
|
90 |
| Malignant neoplasia |
91 |
| Malignant neoplasia Precocious puberty |
92 | Medroxyprogesterone Acetate Tablets, 2.5 mg | Dysfunctional uterine bleeding Precocious puberty Turner’s syndrome |
93 | Medroxyprogesterone Acetate Tablets, 10 mg | Dysfunctional uterine bleeding Malignant neoplasia Precocious puberty Turner’s syndrome |
94 | Medroxyprogesterone Acetate Tablets, 100 mg | Malignant neoplasia |
95 |
|
|
96 |
|
|
|
| |
97 |
| With the written authority of the Permanent Head—
|
|
| |
98 | Methicillin Sodium, B.P., for injection | Endophthalmitis Proven or suspected staphylococcal septicaemia |
99 |
|
|
| With the written authority of the Permanent Head—
| |
100 | Methylphenobarbitone | Epilepsy |
101 | Methylprednisolone Acetate Injection, B.P. |
|
102 | Methyltestosterone Tablets, B.P., 5 mg |
|
103 | Methyltestosterone Tablets, B.P., 25 mg or 50 mg | Carcinoma of the breast Hypogonadism
|
104 | Methysergide Tablets | Carcinoid syndrome
|
105 | Metoclopramide Hydrochloride, B.P., 10 mg Tablets | With the written authority of the Permanent Head—
|
106 | Metoprolol Tartrate |
Hypertension |
107 | Mithramycin | For use in a hospital for—
|
108 |
| Severe intractable pain |
109 | Nandrolone Decanoate Injection, B.P. | With the written authority of the Permanent Head—
|
110 | Nandrolone Phenylpropionate Injection, B.P. | With the written authority of the Permanent Head—
|
111 | Neomycin Tablets, B.P. |
Bowel sterilisation preparatory to major surgery Encephalopathy, hepatic Enteropathogenic E. coli infections in infants |
112 | Nicotinic Acid Tablets, B.P. | Any disease or condition in a pensioner |
113 |
|
|
114 | Norethisterone Acetate, B.P., Tablets, 10 mg | Malignant neoplasia |
115 | Norethisterone Acetate, B.P., Tablets, 2.5 mg | Dysfunctional uterine bleeding Endometriosis Precocious puberty Turner’s syndrome |
116 | Norethisterone Tablets, B.P., 5 mg | Benign mammary dysplasia Dysfunctional uterine bleeding Endometriosis Precocious puberty Turner’s syndrome |
117 | Orphenadrine Hydrochloride Tablets, B.P. | Parkinsonism |
118 | Oxycodone Hydrochloride | Treatment in malignant neoplasia |
119 | Oxymetholone Tablets, B.P | With the written authority of the Permanent Head—
|
120 |
| Cystic fibrosis (mucoviscidosis) Following pancreatico-duodenectomy |
| Pancreatic steatorrhoea | |
| ||
121 |
| With the written authority of the Permanent Head—
|
122 | Pentazocine Lactate Injection, B.P. |
|
123 | Perhexiline Maleate | With the written authority of the Permanent Head—
|
124 | Pericyazine | Chorea Hyperactive states of organic or toxic delirium Major psychoses, including—
Manic-depressive psychosis Paranoid states Schizophrenia Senile dementia Malignant neoplasia (late stage) Radiation sickness
|
125 | Phenelzine Tablets, B.P. | With the written authority of the Permanent Head—
|
126 | Phenobarbitone Tablets, B.P. | Epilepsy |
127 | Phenobarbitone B.P | Epilepsy |
128 | Phenobarbitone Sodium B.P. | Epilepsy |
129 | Phenoxybenzamine Capsules B.P. | With the written authority of the Permanent Head—
|
130 | Pizotifen Malate | Prevention of migraine |
131 | Polyestradiol Phosphate | Carcinoma of the breast Carcinoma of the prostate |
132 | Polyisobutylene | Ileostomy or colostomy conditions |
133 | Polyvinylpyrrolidone and Vinyl Acetate Copolymer | Ileostomy or colostomy conditions |
134 | Potassium Bicarbonate Effervescent Tablets | With the written authority of the Permanent Head—
|
135 |
| Local intra-articular or peri-articular infiltration |
136 |
| Corneal grafts Uveitis |
137 |
| Ulcerative colitis Proctitis |
138 | “PREGESTIMIL” | With the written authority of the Permanent Head—
|
139 | Propantheline Tablets, B.P. | With the written authority of the Permanent Head—
|
140 | Propranolol Tablets, B.P., 160 mg |
|
141 | “PROSOBEE” | With the written authority of the Permanent Head—
|
142 | Pyridoxine Hydrochloride Tablets | Anaemia proved to be responsive to pyridoxine Convulsions responsive to pyridoxine Homocystinuria Primary hyperoxaluria Radiation sickness Sideroblastic (refractory) anaemia
|
143 | Pyrimethamine, B.P., with Dapsone, B.P |
|
144 | Pyrimethamine, B.P., with Sulfadoxine |
|
145 | Riboflavine Tablets | Any disease or condition in a pensioner |
146 |
| Ileostomy or colostomy conditions |
147 | Sodium Cromoglycate, B.P. | With the written authority of the Permanent Head—
|
148 | Sodium Cromoglycate Cartridges, B.P. | Prophylaxis of bronchial asthma |
149 | Sodium Fusidate |
With the written authority of the Permanent Head—
|
150 | Sodium Valproate | Epilepsy |
151 | “SOYALAC” | With the written authority of the Permanent Head—
|
152 | Spironolactone Tablets, B.P. | With the written authority of the Permanent Head—
|
153 | Sterculia | Ileostomy or colostomy conditions |
154 | Sulindac | With the written authority of the Permanent Head—
|
155 |
|
|
| For use with surgical appliances Ileostomy or colostomy conditions | |
156 |
| Carcinoma of the breast |
| Hypogonadism Klinefelter’s syndrome (seminiferous tubule dysgenesis) | |
157 |
| Carcinoma of the breast Gigantism Hypogonadism
|
| ||
158 | Tetracosactrin Zinc Injection, B.P. | With the written authority of the Permanent Head—
|
159 | Thiamine Hydrochloride Tablets, B.P. | Any disease or condition in a pensioner |
160 | Thiopropazate Hydrochloride | Chorea Drug induced dystonias |
161 |
| Chorea Hyperactive states or organic or toxic delirium |
| Major psychoses including—
Malignant neoplasia (late stage) Radiation sickness
| |
162 | Timolol Maleate Eye Drops | Open angle glaucoma |
163 | Tobramycin Sulphate | With the written authority of the Permanent Head—
|
164 | Tranylcypromine Tablets, B.P. | With the written authority of the Permanent Head—
|
165 | Triamcinolone Acetonide Injection | Alopecia areata Granulomata, dermal Keloid Lichen plamus hypertrophic Lichen simplex chronicus Lupus erythematosus, chronic discoid Necrobiosis lipoidica Psoriasis |
166 |
| Chorea Hyperactive states of organic or toxic delirium |
| Major psychoses including—
Malignant neoplasia (late stage) Radiation sickness
| |
167 | Triglycerides Oil, Medium Chain | With the written authority of the Permanent Head—
|
168 | “TRIGLYDE” | With the written authority of the Permanent Head—
|
169 | Trioxysalen | Vitiligo |
170 | Vancomycin Hydrochloride |
Endophthalmitis |
171 | Verapamil Hydrochloride Injection | Cardiac arrhythmias |
172 | Verapamil Hydrochloride Tablets | Angina Cardiac arrhythmias |
173 | Vidarabine |
|
174 | “ZERODOR” | Ileostomy or colostomy conditions |
175 | “ZOFF” |
For use with surgical appliances Ileostomy or colostomy conditions |
1. Notified in the
Commonwealth of Australia Gazette on 28 November 1980.2. Statutory Rules 1960 No. 17 as amended to date. For previous amendments
see Note 2 to Statutory Rules 1980 No. 69 andsee also
0
0
0